col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

55 Results       Page 1

Springer-Verlag: Inflammation Research
  original article Date Title Authors   All Authors
1 [GO] 2023―Oct―14 A suitable model to investigate acute neurological consequences of coronavirus infection Jordane Pimenta, Bruna Da Silva Oliveira, Anna Luiza Diniz Lima, Caroline Amaral Machado, Larisse De Souza Barbosa Lacerda, Leonardo Rossi, et al. (+14)
2 [GO] 2023―Sep―19 Featured immune characteristics of COVID-19 and systemic lupus erythematosus revealed by multidimensional integrated analyses Xingwang Zhao, Mengjie Zhang, Yuying Jia, Wenying Liu, Shifei Li, Cuie Gao, et al. (+4)
3 [GO] 2023―Aug―03 ACE2, ACE, DPPIV, PREP and CAT L enzymatic activities in COVID-19: imbalance of ACE2/ACE ratio and potential RAAS dysregulation in severe cases Raquel Leão Neves, Jéssica Branquinho, Júlia Galanakis Arata, Clarissa Azevedo Bittencourt, Caio Perez Gomes, Michelle Riguetti, et al. (+5)
4 [GO] 2023―Apr―03 Long-COVID fatigue is not predicted by pre-pandemic plasma IL-6 levels in mild COVID-19 Maxim B. Freidin, Nathan Cheetham, Emma L. Duncan, Claire J. Steves, Katherine J. Doores, Michael H. Malim, et al. (+8)
5 [GO] 2023―Apr―03 Clinical manifestations of COVID-19 infection in dialysis patients and protective effect of COVID-19 vaccine Xuehan Zhang, Qingfeng Chen, Gaosi Xu
6 [GO] 2023―Mar―29 Reduction in the number of neutrophils in the broncho-alveolar aspirate is associated with worse prognosis in elderly patients with severe COVID-19 Raquel Duque Nascimento Arifa, Marcela Helena Gonçalves-Pereira, Luciana Santiago, Cecilia Gómez Ravetti, Paula Frizera Vassallo, Fernanda de Fátima Souza Oliveira, et al. (+5)
7 [GO] 2023―Mar―14 Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients N. B. Amaral, T. S. Rodrigues, M. C. Giannini, M. I. Lopes, L. P. Bonjorno, P. I. S. O. Menezes, et al. (+28)
8 [GO] 2023―Jan―08 Evaluation of urinary cysteinyl leukotrienes as biomarkers of severity and putative therapeutic targets in COVID-19 patients Marta Reina-Couto, Mariana Roboredo-Madeira, Patrícia Pereira-Terra, Carolina Silva-Pereira, Sandra Martins, Luísa Teixeira-Santos, et al. (+11)
9 [GO] 2022―Dec―20 SARS-CoV-2-mediated liver injury: pathophysiology and mechanisms of disease Ali Choaib, Elio Issa, Francesca El Choueiry, Jade Nasser Eldin, Khodor Shbaklo, Maryline Alhajj, et al. (+5)
10 [GO] 2022―Nov―23 A common variant close to the “tripwire” linker region of NLRP1 contributes to severe COVID-19 Vinicius N. C. Leal, Leandro M. Paulino, Raylane A. G. Cambui, Thiago G. Zupelli, Suemy M. Yamada, Leonardo A. T. Oliveira, et al. (+17)
11 [GO] 2022―Oct―28 Bioactive compounds as potential angiotensin-converting enzyme II inhibitors against COVID-19: a scoping review Pedro Henrique de Matos, Thalita Prates da Silva, Amanda Benites Mansano, Naiara Cássia Gancedo, Fernanda Stumpf Tonin, Fernando Castilho Pelloso, et al. (+7)
12 [GO] 2022―Aug―08 Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail Shadi Salem Alkhayyat, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Maisra M. El-Bouseary, Amal M. AboKamer, Gaber El-Saber Batiha, Jesus Simal-Gandara
13 [GO] 2022―Jul―31 Type 2 alveolar epithelial cell-derived circulating extracellular vesicle-encapsulated surfactant protein C as a mediator of cardiac inflammation in COVID-19 Mohammad Rudiansyah, Ermias Mergia Terefe, Maria Jade Catalan Opulencia, Walid Kamal Abdelbasset, Dmitry Olegovich Bokov, Amr A. El-Sehrawy, et al. (+4)
14 [GO] 2022―Jul―28 Long-term implications of COVID-19 on bone health: pathophysiology and therapeutics Leena Sapra, Chaman Saini, Bhavuk Garg, Ranjan Gupta, Bhupendra Verma, Pradyumna K. Mishra, Rupesh K. Srivastava
15 [GO] 2022―Jul―24 Targeting ACE2 as a potential prophylactic strategy against COVID-19-induced exacerbation of chronic kidney disease Itsuro Kazama
16 [GO] 2022―Jun―25 The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19 Shima Makaremi, Ali Asgarzadeh, Hamed Kianfar, Alireza Mohammadnia, Vahid Asghariazar, Elham Safarzadeh
17 [GO] 2022―Jun―01 Histamine research advancements in the second year of the COVID-19 pandemic: report of the European Histamine Research Society (EHRS) Ilona Obara, João Paulo S. Fernandes, Ekaterini Tiligada
18 [GO] 2022―Apr―10 Anti-coronavirus vaccines will not accelerate the transition of humanity to a non-pandemic period, but the pandemic will take fewer victims V. V. Oberemok, O. A. Andreeva, K. V. Laikova, I. A. Novikov, Y. V. Puzanova, A. V. Kubyshkin
19 [GO] 2022―Mar―15 COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines Biswajit Biswas, Shagnik Chattopadhyay, Sayantee Hazra, Arman Kunwar Hansda, Ritobrata Goswami
20 [GO] 2022―Feb―26 The prognostic value of S100A calcium binding protein family members in predicting severe forms of COVID-19 Zahra Bagheri-Hosseinabadi, Mohadese Abbasi, Mahmood Kahnooji, Zainab Ghorbani, Mitra Abbasifard
21 [GO] 2022―Feb―14 Cytokine producing ability of peripheral blood cells from COVID-19 patients after unspecific in vitro stimulation Snezana Zivancevic-Simonovic, Danijela Jovanovic, Vojislav Cupurdija, Olivera Milosevic-Djordjevic, Marijana Stanojevic, Milos Marinkovic, et al. (+4)
22 [GO] 2022―Feb―03 Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation Aldo Bonaventura, Alessandra Vecchié, Lorenzo Dagna, Flavio Tangianu, Antonio Abbate, Francesco Dentali
23 [GO] 2021―Nov―30 Severity of SARS-CoV-2 infection is linked to double-negative (CD27- IgD-) B cell subset numbers Rodrigo Cervantes-Díaz, Víctor Andrés Sosa-Hernández, Jiram Torres-Ruíz, Sandra Romero-Ramírez, Mariana Cañez-Hernández, Alfredo Pérez-Fragoso, et al. (+6)
24 [GO] 2021―Nov―21 Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies Wissam H. Faour, Ali Choaib, Elio Issa, Francesca El Choueiry, Khodor Shbaklo, Maryline Alhajj, et al. (+4)
25 [GO] 2021―Nov―18 Correction to: Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study Fabio Cherubini, Antonio Cristiano, Alessandra Valentini, Sergio Bernardini, Marzia Nuccetelli
26 [GO] 2021―Nov―05 Gut microbiome, Vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infection Santosh Shenoy
27 [GO] 2021―Nov―01 Metabolic and inflammatory health in SARS-CoV-2 and the potential role for habitual exercise in reducing disease severity Frank E. Marino, Nicole T. Vargas, Melissa Skein, Tegan Hartmann
28 [GO] 2021―Oct―30 Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: a multicenter, prospective study (CalCov study) Luis García de Guadiana-Romualdo, Carlos Rodríguez Rojas, Daniel Morell-García, David Andaluz-Ojeda, María Dolores Rodríguez Mulero, Enrique Rodríguez-Borja, et al. (+24)
29 [GO] 2021―Sep―29 The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study Nikita V. Lomakin, Bulat A. Bakirov, Denis N. Protsenko, Vadim I. Mazurov, Gaziyavdibir H. Musaev, Olga M. Moiseeva, et al. (+14)
30 [GO] 2021―Sep―24 Adverse Ocular Events following COVID-19 Vaccination Taher K. Eleiwa, Eric D. Gaier, Abid Haseeb, Reem H. ElSheikh, Ahmed B. Sallam, Abdelrahman M. Elhusseiny
31 [GO] 2021―Aug―26 COVID-19 disrupts the blood-testis barrier through the induction of inflammatory cytokines and disruption of junctional proteins Tahmineh Peirouvi, Abbas Aliaghaei, Bahram Eslami Farsani, Sanaz Ziaeipour, Vahid Ebrahimi, Mehdi Forozesh, et al. (+8)
32 [GO] 2021―Jul―20 SARS-CoV-2 and pathological matrix remodeling mediators Imen Guizani, Nesrine Fourti, Wiem Zidi, Moncef Feki, Monia Allal-Elasmi
33 [GO] 2021―Jun―26 How could perfluorocarbon affect cytokine storm and angiogenesis in coronavirus disease 2019 (COVID-19): role of hypoxia-inducible factor 1α Narges Moasefi, Mehdi Fouladi, Amir Hossein Norooznezhad, Reza Yarani, Adibeh Rahmani, Kamran Mansouri
34 [GO] 2021―Jun―04 The role of 5-lipoxygenase in the pathophysiology of COVID-19 and its therapeutic implications Nohora Cristina Ayola-Serrano, Namrata Roy, Zareena Fathah, Mohammed Moustapha Anwar, Bivek Singh, Nour Ammar, et al. (+7)
35 [GO] 2021―Jun―04 Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report Luca Spiro Santovito, Graziano Pinna
36 [GO] 2021―May―10 A simple and readily available inflammation-based risk scoring system on admission predicts the need for mechanical ventilation in patients with COVID-19 Luis M. Amezcua-Guerra, Karen Audelo, Juan Guzmán, Diana Santiago, Julieta González-Flores, Carlos García-Ávila, et al. (+5)
37 [GO] 2021―May―06 Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study Fabio Cherubini, Antonio Cristiano, Alessandra Valentini, Sergio Bernardini, Marzia Nuccetelli
38 [GO] 2021―Mar―19 Association of alpha-1-antitrypsin deficiency with vitamin D status: who is most at risk of getting severe COVID-19? Ghazaleh Shimi, Hamid Zand
39 [GO] 2021―Feb―28 COVID-19 illness and autoimmune diseases: recent insights Juan Li, Hong-Hui Liu, Xiao-Dong Yin, Cheng-Cheng Li, Jing Wang
40 [GO] 2021―Feb―19 Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection Zahra Bahari, Zohreh Jangravi, Hassan Ghoshooni, Mohammad Reza Afarinesh, Gholam Hossein Meftahi
41 [GO] 2021―Jan―01 Relationship between the dynamic changes of serum 2019-nCoV IgM/IgG and patient immunity after 6 month hospital discharge Yinfeng Shen, Yuanming Ba, Yaling Hu, Linqun Wang, Weinan Li
42 [GO] 2020―Dec―21 Potential roles of mitochondrial cofactors in the adjuvant mitigation of proinflammatory acute infections, as in the case of sepsis and COVID-19 pneumonia Giovanni Pagano, Carla Manfredi, Federico V. Pallardó, Alex Lyakhovich, Luca Tiano, Marco Trifuoggi
43 [GO] 2020―Nov―18 Histamine receptors and COVID-19 Madeleine Ennis, Katerina Tiligada
44 [GO] 2020―Oct―30 SARS-CoV-2 will continue to circulate in the human population: no worries with state-of-the-art research and dependably useful results Volodymyr V. Oberemok, Kateryna V. Laikova, Kseniya A. Yurchenko, Irina I. Fomochkina, Anatolii V. Kubyshkin
45 [GO] 2020―Oct―20 Inflammasome formation in the lungs of patients with fatal COVID-19 Stefano Toldo, Rossana Bussani, Vincenzo Nuzzi, Aldo Bonaventura, Adolfo G. Mauro, Antonio Cannatà, et al. (+5)
46 [GO] 2020―Sep―28 Don't worry! The next generation would be more resistant to SARS-CoV-2 Joseph J. Bevelacqua, Seyed Mohammad Javad Mortazavi
47 [GO] 2020―Sep―12 The coagulopathy, endotheliopathy, and vasculitis of COVID-19 Toshiaki Iba, Jean Marie Connors, Jerrold H. Levy
48 [GO] 2020―Aug―07 Coronavirus (Covid-19) sepsis: revisiting mitochondrial dysfunction in pathogenesis, aging, inflammation, and mortality Santosh Shenoy
49 [GO] 2020―Jul―12 SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in ‘lasso’ for the multi-faced virus V. V. Oberemok, K. V. Laikova, K. A. Yurchenko, N. A. Marochkin, I. I. Fomochkina, A. V. Kubyshkin
50 [GO] 2020―Jun―11 The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of “inflame-aging” Gholam Hossein Meftahi, Zohreh Jangravi, Hedayat Sahraei, Zahra Bahari
51 [GO] 2020―Jun―02 Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms Paulo Ricardo Criado, Beatrice Martinez Zugaib Abdalla, Isabelle Carvalho de Assis, Cristina van Blarcum de Graaff Mello, Gabriela Cacciolari Caputo, Ingrid Campos Vieira
52 [GO] 2020―May―28 The unleashing of the immune system in COVID-19 and sepsis: the calm before the storm? Salvatore Bellinvia, Christopher J. Edwards, Matteo Schisano, Paolo Banfi, Matteo Fallico, Paolo Murabito
53 [GO] 2020―May―05 SARS-CoV-2-mediated inflammatory response in lungs: should we look at RAGE? Armando Rojas, Ileana Gonzalez, Miguel A. Morales
54 [GO] 2020―Apr―30 SARS-CoV-2 will continue to circulate in the human population: an opinion from the point of view of the virus-host relationship Volodymyr V. Oberemok, Kateryna V. Laikova, Kseniya A. Yurchenko, Irina I. Fomochkina, Anatolii V. Kubyshkin
55 [GO] 2020―Mar―29 The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients Jing Yuan, Rougrong Zou, Lijiao Zeng, Shanglong Kou, Jianfeng Lan, Xiaohe Li, et al. (+8)

55 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec